Two Doses of BNT162b2 Vaccine Protect Against MIS-C
Two doses of Pfizer-BioNTech vaccine have estimated effectiveness of 91 percent against MIS-C in children aged 12 to 18 years
COVID-19 Survivors Overestimate Lingering Taste Impairment
Authors say validated psychophysical tests can better identify true burden of chemosensory dysfunction
COVID-19 Incidence Up With Exposure to Airborne Pollutants
Long-term exposure to low levels of air pollutants linked to increased incidence of COVID-19 in city in Northern Italy
COVID-19 Vaccination Linked to Small Change in Menstrual Cycle Length
Difference in change in cycle length between vaccinated and unvaccinated cohorts less than one day in adjusted models
Use of Certain Prescription Meds Linked to COVID-19 Mortality
Discontinuation of ACE-I, ARB, metformin associated with elevated risk for death among hospitalized COVID-19 patients
Severe COVID-19 Outcomes Rare After Primary Vaccination
Risk higher for people who were aged 65 years or older, immunosuppressed, or had at least one of six underlying conditions
FDA Warns Against Using At-Home COVID-19 Test Swabs in the Throat
Throat swabs are common in some countries, but most self-tests in the United States require nasal samples
Amid COVID-19 Test Shortages, Price Gouging Is on the Rise
Attorney General offices around the country have reported receiving complaints or hearing stories of price gouging
COVID-19 Vaccines Significantly Cut MIS-C Risk in Teens
Of 107 children hospitalized with multisystem inflammatory syndrome in children, none were fully vaccinated
Vaccination Seems Less Protective Against Transmission of Delta Variant
Reduction in transmission of SARS-CoV-2 associated with COVID-19 vaccination smaller for delta variant versus alpha variant
